Orthofix International Announces New Agreement To Expand Distribution of Spine Implants in the U.K.

BOSTON–(BUSINESS WIRE)–Orthofix International N.V. (NASDAQ: OFIX – News) (the Company) announced today it has signed an agreement with the MBA Group (MBA) to expand the distribution of the Company’s spine implant and biologic devices in the United Kingdom.

As the largest private independent distributor of orthopedic devices in Europe, MBA generated more than $100 million in total sales in 2008. After having been Orthofix’s exclusive distributor of orthopedic devices in Spain and Portugal for more than 20 years, MBA expanded their relationship with Orthofix in 2008 becoming the Company’s exclusive distributor of spine implant products in Spain and Portugal. The new five-year agreement with MBA is effective as of May 1st.

“MBA has been a key partner during Orthofix’s growth over the last 20 years and, after successfully expanding our relationship last year to include the distribution of our spine implant products in Spain and Portugal, we are excited to further expand our spine distribution agreement with them into the important U.K. market,” said Alan Milinazzo, President and CEO of Orthofix International.